Movement Alert｜BEONE MEDICINES Declines 3.01% in Regular Trading, CEO Sells Shares Worth Nearly $20 Million

Market Focus08-14

On August 14, BEONE MEDICINES (06160.HK) fell 3.01% in regular trading to HKD 213.0, with turnover of HKD 272 million.

On the news front, company co-founder and CEO John Oyler sold approximately 713,600 ordinary shares on August 12 at an average price of USD 27.55 per share, totaling approximately USD 19.66 million. Following the disposal, his stake decreased from 3.86% to 3.82%. The selling pressure from executive share reduction weighed on market sentiment.

Within the Biotechnology sector where BEONE MEDICINES belongs, the broader sector showed notable weakness. Among individual stocks, AKESO down 5.55%, ZAI LAB down 5.10%, REMEGEN down 1.39%, INNOVENT BIO down 0.26%, and 3SBIO up 0.06%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1145620803?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 10:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1145620803","market":"hk","top_or_hot":-1,"title":"Movement Alert｜BEONE MEDICINES Declines 3.01% in Regular Trading, CEO Sells Shares Worth Nearly $20 Million","media":"Market Focus","content":"<p><p>On August 14, BEONE MEDICINES (06160.HK) fell 3.01% in regular trading to HKD 213.0, with turnover of HKD 272 million.</p><p>On the news front, company co-founder and CEO John Oyler sold approximately 713,600 ordinary shares on August 12 at an average price of USD 27.55 per share, totaling approximately USD 19.66 million. Following the disposal, his stake decreased from 3.86% to 3.82%. The selling pressure from executive share reduction weighed on market sentiment.</p><p>Within the Biotechnology sector where BEONE MEDICINES belongs, the broader sector showed notable weakness. Among individual stocks, AKESO down 5.55%, ZAI LAB down 5.10%, REMEGEN down 1.39%, INNOVENT BIO down 0.26%, and 3SBIO up 0.06%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜BEONE MEDICINES Declines 3.01% in Regular Trading, CEO Sells Shares Worth Nearly $20 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜BEONE MEDICINES Declines 3.01% in Regular Trading, CEO Sells Shares Worth Nearly $20 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-14 10:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 14, BEONE MEDICINES (06160.HK) fell 3.01% in regular trading to HKD 213.0, with turnover of HKD 272 million.</p><p>On the news front, company co-founder and CEO John Oyler sold approximately 713,600 ordinary shares on August 12 at an average price of USD 27.55 per share, totaling approximately USD 19.66 million. Following the disposal, his stake decreased from 3.86% to 3.82%. The selling pressure from executive share reduction weighed on market sentiment.</p><p>Within the Biotechnology sector where BEONE MEDICINES belongs, the broader sector showed notable weakness. Among individual stocks, AKESO down 5.55%, ZAI LAB down 5.10%, REMEGEN down 1.39%, INNOVENT BIO down 0.26%, and 3SBIO up 0.06%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06160","symbol_name":"百济神州","start_time":0,"source_url":"","article_id":"1145620803","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1145620803","pubTimestamp":1786674720,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 14, BEONE MEDICINES (06160.HK) fell 3.01% in regular trading to HKD 213.0, with turnover of HKD 272 million.On the news front, company co-founder and CEO John Oyler sold approximately...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06160":"百济神州"},"translate_title":"走势警报|BEONE MEDICINES常规交易下跌3.01%，CEO出售价值近2000万美元的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06160":1},"content_text":"On August 14, BEONE MEDICINES (06160.HK) fell 3.01% in regular trading to HKD 213.0, with turnover of HKD 272 million.On the news front, company co-founder and CEO John Oyler sold approximately 713,600 ordinary shares on August 12 at an average price of USD 27.55 per share, totaling approximately USD 19.66 million. Following the disposal, his stake decreased from 3.86% to 3.82%. The selling pressure from executive share reduction weighed on market sentiment.Within the Biotechnology sector where BEONE MEDICINES belongs, the broader sector showed notable weakness. Among individual stocks, AKESO down 5.55%, ZAI LAB down 5.10%, REMEGEN down 1.39%, INNOVENT BIO down 0.26%, and 3SBIO up 0.06%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1145620803","isCrawlerRequest":true}